Table of Contents Table of Contents
Previous Page  470 / 916 Next Page
Information
Show Menu
Previous Page 470 / 916 Next Page
Page Background

S466

25th European Congress of Psychiatry / European Psychiatry 41S (2017) S465–S520

EV0191

Bipolar disorder and substance use

disorders in a Tunisian sample

S. Ben Mustapha

, W. Homri , R. Labbane

Razi Hospital, service de psychiatrie C, Mannouba, Tunisia

Corresponding author.

Aims

Describe the sociodemographic and clinical profile of

patients suffering from bipolar disorder and substance use disor-

ders comorbidity and assess the consequences of this comorbidity

on prognosis and evolution of bipolar disorder,

Methods

A case-control study, 100 euthymic patients treated for

bipolar disorder, recruited in the department of psychiatry C of

Razi hospital. Two groups of 50 patients were individualized by the

presence or not of substance use disorders comorbidity. The two

groups were compared for sociodemographic, clinical, therapeutic

and historical characteristics.

Results

Compared to bipolar patients without addictive comor-

bidity, those with this comorbidity had the following character-

istics: we found more male, less family cohesion, more domestic

violence, more criminal records, more time spent abroad, more

personality disorders especially antisocial and borderline, fewer

triggers of bipolar illness, moremood episodes, more psychotic fea-

tures, higher impulsivity BIS-10 score, an increased need to put in

a neuroleptic long term treatment, poor adherence to treatment,

lower response to treatment, lower score of global assessment of

functioning (GAF), more rapid cycles, shorter period of remission,

longer duration of the last mood episode, poor socio-professional

integration and poor quality of intervals between mood episodes.

Conclusions

It seems important to insist on the identification and

the treatment of bipolar disorder or substance use disorders when

one of them is diagnosed. This needs to set up urgently facilities

and care structures for patients with substance use disorders and

to create more addiction consultations.

Disclosure of interest

The authors have not supplied their decla-

ration of competing interest.

http://dx.doi.org/10.1016/j.eurpsy.2017.01.521

EV0192

Bipolar disorder and co-occurring

cannabis use disorders

S. Ben Mustapha

, W. Homri , L. Jouini , R. Labbane

Razi Hospital, service de psychiatrie C, Mannouba, Tunisia

Corresponding author.

Aims

Assess the prevalence of cannabis use disorders (CUD) in

patients with bipolar disorder, describe the demographic and clini-

cal profile socio bipolar patientswith comorbid addictive and assess

the implications of this comorbidity on prognosis and evolution of

bipolar disorder.

Methods

A case-control study, 100 euthymic patients treated for

bipolar disorder, recruited in the department of psychiatry C of

Razi hospital. Two groups were individualized by the presence or

not of cannabis use disorders comorbidity. The two groups were

compared for sociodemographic, clinical, therapeutic and historical

characteristics.

Results

The prevalence of CUD was 27.53% (

n

= 19) in our sample.

Comparing bipolar patients according to the presence or absence

of CUD, we found the following results with patients with CUD

comorbidity: younger, mostly male, a disturbed family dynamic,

low educational level, poor socio-economic conditions, more time

abroad history, more suicide attempts in history, more criminal

record, more psychiatric family history, an earlier onset of the

disease, a longer duration of undiagnosed bipolar disorder, more

personality disorder, more frequent presence of a triggering factor

for bipolar disorder, more psychotic features duringmood episodes,

more need of antipsychotic long-term treatment.

Conclusions

The frequency of CUD in BD is higher than the preva-

lence in the general population and CUD is a factor in the evolution

and prognosis of bipolar disorder and promotes the development

of mood disorders in predisposed patients.

Disclosure of interest

The authors have not supplied their decla-

ration of competing interest.

http://dx.doi.org/10.1016/j.eurpsy.2017.01.522

EV0193

Comparison of insight in bipolar

disorder with and without co-morbid

substance use disorders

S. Ben Mustapha

, W. Homri , L. Jouini , R. Labbane

Razi Hospital, service de psychiatrie C, Mannouba, Tunisia

Corresponding author.

Aims

Compare the level of insight in bipolar disorder (BD) with

and without substance use disorders (SUD).

Methods

Case-control study during a period of six months from

July 2015 to December 2015. One hundred euthymic patients with

BD (type I, II or unspecified) were recruited in the department of

psychiatry C Razi Hospital, during their follow-up. Two groupswere

individualized by the presence or not of

SUDco-morbidity.We

eval-

uated and compared insight with Birchwood IS scale (with its three

sub-scales),

Results

The mean age was 40.6 years (

±

16.4). The sex ratio was 2.

Sixty-six percent of patients were diagnosed with bipolar disorder

type 1 and type 2 bipolar disorder remains.

There is no statistically significant difference between bipolar with

and without SUD in terms of quality of insight.

As for the subscales, bipolar patients with comorbid SUD had lower

scores of awareness of any symptoms, whereas there was no sig-

nificant difference regarding the awareness of illness and the need

for treatment between the two populations.

Conclusions

Co-morbid SUD can affect the quality of insight

in individuals with BD. Patients with this co-morbidity should

be targeted for intensive psycho-educational measures and psy-

chotherapeutic interventions focused on the improvement of

insight.

Disclosure of interest

The authors have not supplied their decla-

ration of competing interest.

http://dx.doi.org/10.1016/j.eurpsy.2017.01.523

EV0194

Attempted suicide in people with

co-occurring bipolar and substance

use disorders

S. Ben Mustapha

, W. Homri , L. Jouini , R. Labbane

Razi Hospital, service de psychiatrie C, Mannouba, Tunisia

Corresponding author.

Aims Study the impact of SUD co-morbidity on suicide risk in

patients with BD.

Methods

Case-control study during a period of six months from

July 2015 to December 2015. One hundred euthymic patients with

BD (type I, II or unspecified) were recruited in the department of

psychiatry C Razi Hospital, during their follow-up. Two groupswere

individualized by the presence or not of a SUD co-morbidity.

Results

The average age of patients with SUD was 44.02 years

that of the patients without SUD was 44.12 years.

The sex ratio of patients with SUD was 5.25 and that of patients

without SUD were 0.61.

Twenty-six percent of patients with SUD comorbidity had a history

of suicide attempts. Fourteen percent of patients without SUD had

a history of suicide attempts.

The association between SUD and history of suicide attempts was

not significant (

P

= 0.134).